Adrover Miquel

Dr. Adrover Miquel

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2024 in Biophysical Reviews
Verified
Journal Article
Open access
PDF file
AMAna Belén Uceda Mayo
Ana Belén Uceda Mayo
LMLaura Mariño
Laura Mariño
RCRodrigo Casasnovas
Rodrigo Casasnovas
AMAdrover Miquel
Adrover Miquel
The formation of a heterogeneous set of advanced glycation end products (AGEs) is the final outcome of a non-enzymatic process that occurs in vivo on long-life biomolecules. This process, known as glycation, starts with the reaction between reducing sugars, or their autoxidation products, with the amino groups of proteins, DNA, or lipids, thus gaining relevance under hyperglycemic conditions. Once AGEs are formed, they might affect the biological function of the biomacromolecule and, therefore, induce the development of pathophysiological events. In fact, the accumulation of AGEs has been pointed as a triggering factor of obesity, diabetes-related diseases, coronary artery disease, neurological disorders, or chronic renal failure, among others. Given the deleterious consequences of glycation, evolution has designed endogenous mechanisms to undo glycation or to prevent it. In addition, many exogenous molecules have also emerged as powerful glycation inhibitors. This review aims to provide an overview on what glycation is. It starts by explaining the similarities and differences between glycation and glycosylation. Then, it describes in detail the molecular mechanism underlying glycation reactions, and the bio-molecular targets with higher propensity to be glycated. Next, it discusses the precise effects of glycation on protein structure, function, and aggregation, and how computational chemistry has provided insights on these aspects. Finally, it reports the most prevalent diseases induced by glycation, and the endogenous mechanisms and the current therapeutic interventions against it.

1 July 2010 in Journal of Biological Chemistry
Verified
Journal Article
Open access
AMAdrover Miquel
Adrover Miquel
KPKris Pauwels
Kris Pauwels
SPStephanie Prigent
Stephanie Prigent
CCCesira de Chiara
Cesira de Chiara
ZXZhou Xu
Zhou Xu
HRHuman Rezaei
Human Rezaei
Aggregation and misfolding of the prion protein (PrP) are thought to be the cause of a family of lethal neurodegenerative diseases affecting humans and other animals. Although the structures of PrP from several species have been solved, still little is known about the mechanisms that lead to the misfolded species. Here, we show that the region of PrP comprising the hairpin formed by the helices H2 and H3 is a stable independently folded unit able to retain its secondary and tertiary structure also in the absence of the rest of the sequence. We also prove that the isolated H2H3 is highly fibrillogenic and forms amyloid fibers morphologically similar to those obtained for the full-length protein. Fibrillization of H2H3 but not of full-length PrP is concomitant with formation of aggregates. These observations suggest a "banana-peeling" mechanism for misfolding of PrP in which H2H3 is the aggregation seed that needs to be first exposed to promote conversion from a helical to a beta-rich structure.

1 August 2014 in Biomacromolecules
Verified
Journal Article
Closed access
AMAdrover Miquel
Adrover Miquel
LMLaura Mariño
Laura Mariño
PSPilar Sanchis
Pilar Sanchis
KPKris Pauwels
Kris Pauwels
YKYvonne Kraan
Yvonne Kraan
JDJosefa Donoso
Josefa Donoso

1 September 2019 in Antioxidants
Verified
Journal Article
Open access
PDF file
RRRafael Ramis
Rafael Ramis
JOJoaquin Ortega-Castro
Joaquin Ortega-Castro
CCCarmen Caballero
Carmen Caballero
RCRodrigo Casasnovas
Rodrigo Casasnovas
ACAntonia Cerrillo
Antonia Cerrillo
JFJuan Frau
Juan Frau
Pyridoxamine, one of the natural forms of vitamin B6, is known to be an effective inhibitor of the formation of advanced glycation end products (AGEs), which are closely related to various human diseases. Pyridoxamine forms stable complexes with metal ions that catalyze the oxidative reactions taking place in the advanced stages of the protein glycation cascade. It also reacts with reactive carbonyl compounds generated as byproducts of protein glycation, thereby preventing further protein damage. We applied Density Functional Theory to study the primary antioxidant activity of pyridoxamine towards three oxygen-centered radicals (•OOH, •OOCH3 and •OCH3) to find out whether this activity may also play a crucial role in the context of protein glycation inhibition. Our results show that, at physiological pH, pyridoxamine can trap the •OCH3 radical, in both aqueous and lipidic media, with rate constants in the diffusion limit (>1.0 × 108 M − 1 s − 1 ). The quickest pathways involve the transfer of the hydrogen atoms from the protonated pyridine nitrogen, the protonated amino group or the phenolic group. Its reactivity towards •OOH and •OOCH3 is smaller, but pyridoxamine can still scavenge them with moderate rate constants in aqueous media. Since reactive oxygen species are also involved in the formation of AGEs, these results highlight that the antioxidant capacity of pyridoxamine is also relevant to explain its inhibitory role on the glycation process.

1 April 2012 in Journal of Molecular Biology
Verified
Journal Article
Closed access
AMAdrover Miquel
Adrover Miquel
GMGabriel Martorell
Gabriel Martorell
SMStephen R. Martin
Stephen R. Martin
DUDunja Urosev
Dunja Urosev
PKPeter Konarev
Peter Konarev
APAnnalisa Pastore
Annalisa Pastore

11 June 2014 in Protein Science
Verified
Journal Article
Open access
PDF file
CIClara Iannuzzi
Clara Iannuzzi
AMAdrover Miquel
Adrover Miquel
RPRita Puglisi
Rita Puglisi
RYRobert Yan
Robert Yan
Piero A. TemussiPiero A. Temussi
Piero A. Temussi
APAnnalisa Pastore
Annalisa Pastore
Understanding the factors that determine protein stability is interesting because it directly reflects the evolutionary pressure coming from function and environment. Here, we have combined experimental and computational methods to study the stability of IscU, a bacterial scaffold protein highly conserved in most organisms and an essential component of the iron–sulfur cluster biogenesis pathway. We demonstrate that the effect of zinc and its consequence strongly depend on the sample history. IscU is a marginally stable protein at low ionic strength to the point that undergoes cold denaturation at around −8°C with a corresponding dramatic decrease of enthalpy, which is consistent with the fluxional nature of the protein. Presence of constitutively bound zinc appreciably stabilizes the IscU fold, whereas it may cause protein aggregation when zinc is added back posthumously. We discuss how zinc coordination can be achieved by different side chains spatially available and all competent for tetrahedral coordination. The individual absence of some of these residues can be largely compensated by small local rearrangements of the others. We discuss the potential importance of our findingsin vitrofor the functionin vivoof the protein.